{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:06:09Z","timestamp":1794575169131,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Bipolar Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lithium has long been considered the gold-standard pharmacological treatment for the maintenance treatment of bipolar disorders (BD) which is supported by a wide body of evidence. Prior research has shown a steady decline in lithium prescriptions during the last two decades. We aim to identify potential factors explaining this decline across the world with an anonymous worldwide survey developed by the International Society for Bipolar Disorders (ISBD) Task Force \u201cRole of Lithium in Bipolar Disorders\u201d and distributed by diverse academic and professional international channels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 886 responses were received of which 606 completed the entire questionnaire while 206 completed it partially. Respondents were from 43 different countries comprising all continents. Lithium was the most preferred treatment option for the maintenance of BD patients (59%). The most relevant clinical circumstances in which lithium was the preferred option were in patients with BD I (53%), a family history of response (18%), and a prior response during acute treatment (17%). In contrast, Lithium was not the preferred option in case of patients\u00b4 negative beliefs and\/or attitudes towards lithium (13%), acute side-effects or tolerability problems (10%) and intoxication risk (8%). Clinicians were less likely to prefer lithium as a first option in BD maintenance phase when practising in developing economy countries [X2 (1, N\u2009=\u2009430)\u2009=\u20099465, p\u2009=\u20090.002) ] and private sectors [X2 (1, N\u2009=\u2009434)\u2009=\u20098191, p\u2009=\u20090.004)].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clinicians\u2019 preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders appear to be affected by both the patients\u2019 beliefs and the professional contexts where clinicians provide their services. More research involving patients is needed for identifying their attitudes toward lithium and factors affecting its use, particularly in developing economies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40345-023-00301-y","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T08:02:03Z","timestamp":1685174523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinicians\u2019 preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force"],"prefix":"10.1186","volume":"11","author":[{"given":"Diego","family":"Hidalgo-Mazzei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Mantingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"P\u00e9rez de Mendiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Samalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Undurraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Strejilevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Severus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"issue":"6","key":"301_CR1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1017\/S0033291713001943","volume":"44","author":"LH Andrade","year":"2014","unstructured":"Andrade LH, Alonso J, Mneimneh Z, Wells JE, Al-Hamzawi A, Borges G, et al. Barriers to mental health treatment: results from the WHO World Mental Health surveys. Psychol Med. 2014;44(6):1303\u201317.","journal-title":"Psychol Med"},{"key":"301_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2022.03.007","volume":"60","author":"M Bauer","year":"2022","unstructured":"Bauer M. Lithium: What can we do to overcome the discrepancies between evidence,guideline recommendations and clinical practice? Eur Neuropsychopharmacol. 2022;60:1\u20133.","journal-title":"Eur Neuropsychopharmacol"},{"key":"301_CR3","doi-asserted-by":"crossref","first-page":"112965","DOI":"10.1016\/j.psychres.2020.112965","volume":"289","author":"J Bohlken","year":"2020","unstructured":"Bohlken J, Bauer M, Kostev K. Drug treatment for patients with bipolar disorders in psychiatric practices in Germany in 2009 and 2018. Psychiatry Res. 2020;289:112965.","journal-title":"Psychiatry Res."},{"key":"301_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003013","author":"SS Burgess","year":"2001","unstructured":"Burgess SS, Geddes J, Hawton KK, Taylor MJ, Townsend E, Jamison K, et al. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. 2001. https:\/\/doi.org\/10.1002\/14651858.CD003013.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"301_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bdi.13031","volume":"23","author":"AF Carvalho","year":"2021","unstructured":"Carvalho AF, Solmi M, Husain MI, Berk M, Vieta E. The rebirth of lithium as the archetypal mood stabilizer. Bipolar Disord. 2021;23(2):211\u20132.","journal-title":"Bipolar Disord"},{"issue":"6","key":"301_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1192\/bjp.187.6.559","volume":"187","author":"D Chisholm","year":"2005","unstructured":"Chisholm D, Van Ommeren M, Ayuso-Mateos JL, Saxena S. Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder. Br J Psychiatry. z2005;187(6):559\u201367.","journal-title":"Br J Psychiatry"},{"issue":"23","key":"301_CR7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2018.16865","volume":"320","author":"WYS Chou","year":"2018","unstructured":"Chou WYS, Oh A, Klein WMP. Addressing health-related misinformation on social media. JAMA. 2018;320(23):2417\u20138.","journal-title":"JAMA"},{"issue":"1","key":"301_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-020-00204-2","volume":"9","author":"X de P\u00e9rez","year":"2021","unstructured":"de P\u00e9rez X, Hidalgo-Mazzei D, Vieta E, Gonz\u00e1lez-Pinto A. Overview of lithium\u2019s use: a nationwide survey. Int J Bipolar Disord. 2021;9(1):1\u20138.","journal-title":"Int J Bipolar Disord"},{"key":"301_CR9","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2147\/NDT.S106479","volume":"12","author":"L Dell\u2019Osso","year":"2016","unstructured":"Dell\u2019Osso L, del Grande C, Gesi C, Carmassi C, Musetti L. A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts. Neuropsychiatr Dis Treat. 2016;12:1687.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"301_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.euroneuro.2021.10.003","volume":"54","author":"KN Fountoulakis","year":"2022","unstructured":"Fountoulakis KN, Tohen M, Zarate CA. Lithium treatment of Bipolar disorder in adults: a systematic review of randomized trials and meta-analyses. Eur Neuropsychopharmacol. 2022;54:100.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"301_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-022-00250-y","volume":"10","author":"FA Gomes","year":"2022","unstructured":"Gomes FA, Brietzke E, Bauer M, Post RM. A call for improving lithium literacy among clinicians and patients. Int J Bipolar Disord. 2022;10(1):1\u20132.","journal-title":"Int J Bipolar Disord"},{"key":"301_CR12","doi-asserted-by":"crossref","first-page":"104266","DOI":"10.1016\/j.neubiorev.2021.07.011","volume":"134","author":"S Gomes-da-Costa","year":"2022","unstructured":"Gomes-da-Costa S, Marx W, Corponi F, Anmella G, Murru A, Pons-Cabrera MT, et al. Lithium therapy and weight change in people with bipolar disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;134:104266.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"301_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-020-00203-3","volume":"8","author":"D Grillault Laroche","year":"2020","unstructured":"Grillault Laroche D, Etain B, Severus E, Scott J, Bellivier F. Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD\/IGSLI task force on treatment with lithium. Int J Bipolar Disord. 2020;8(1):1\u201313.","journal-title":"Int J Bipolar Disord"},{"key":"301_CR14","doi-asserted-by":"crossref","first-page":"102549","DOI":"10.1016\/j.ajp.2021.102549","volume":"57","author":"S Grover","year":"2021","unstructured":"Grover S, Avasthi A, Chakravarty R, Dan A, Chakraborty K, Neogi R, et al. Prescription patterns in clinically stable patients with bipolar disorder: findings from the bipolar disorder course and outcome from India (BiD-CoIN) study. Asian J Psychiatr. 2021;57:102549.","journal-title":"Asian J Psychiatr"},{"key":"301_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpsmen.2011.08.001","author":"O Heeren","year":"2011","unstructured":"Heeren O, S\u00e1nchez De Carmona M, V\u00e1squez G, C\u00f3rdoba R, Forero J, Madrid L, et al. Psychopharmacological treatment of bipolar disorder in Latin American. Revista de Psiquiatr\u00eda y Salud Mental. 2011. https:\/\/doi.org\/10.1016\/j.rpsmen.2011.08.001.","journal-title":"Revista de Psiquiatr\u00eda y Salud Mental"},{"key":"301_CR16","unstructured":"International Monetary Fund (IMF). World economic and financial surveys world economic outlook database\u2014WEO groups and aggregates information. 2022."},{"issue":"2","key":"301_CR17","first-page":"135","volume":"4","author":"A Janet","year":"2009","unstructured":"Janet A, Butler DT. A survey of lithium monitoring and prescribing patterns. Int J Psychiatry Clin Pract. 2009;4(2):135\u20138.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"1","key":"301_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40345-019-0145-0","volume":"7","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Young AH. Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy. Int J Bipolar Disord. 2019;7(1):10.","journal-title":"Int J Bipolar Disord"},{"issue":"2","key":"301_CR19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/scs.12531","volume":"32","author":"K J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen K, Rendtorff JD. Patient participation in mental health care\u2013perspectives of healthcare professionals: an integrative review. Scand J Caring Sci. 2018;32(2):490\u2013501.","journal-title":"Scand J Caring Sci"},{"key":"301_CR20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2016.01.043","volume":"195","author":"A Karanti","year":"2016","unstructured":"Karanti A, Kardell M, Lundberg U, Land\u00e9n M. Changes in mood stabilizer prescription patterns in bipolar disorder. J Affect Disord. 2016;195:50\u20136.","journal-title":"J Affect Disord"},{"issue":"2","key":"301_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.13070","volume":"140","author":"LV Kessing","year":"2019","unstructured":"Kessing LV. Lithium as the drug of choice for maintenance treatment in bipolar disorder. Acta Psychiatr Scand. 2019;140(2):91\u20133.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"301_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.13070","volume":"140","author":"LV Kessing","year":"2019","unstructured":"Kessing LV. Lithium as the drug of choice for maintenance treatment in bipolar disorder. Acta Psychiatr Scand. 2019;140(2):91\u20133.","journal-title":"Acta Psychiatr Scand"},{"issue":"14","key":"301_CR23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jama.2022.17191","volume":"328","author":"D Khullar","year":"2022","unstructured":"Khullar D. Social media and medical misinformation. JAMA. 2022;328(14):1393\u20134.","journal-title":"JAMA"},{"issue":"1","key":"301_CR24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.9758\/cpn.2022.20.1.61","volume":"28","author":"SK Lin","year":"2022","unstructured":"Lin SK, Yang SY, Park SC, Jang OJ, Zhu X, Xiang YT, et al. Prescription patterns for bipolar disorder in Asian Countries: findings from research on asian prescription pattern-bipolar disorder. Clin Psychopharmacol Neurosci. 2022;28(1):61\u20139.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"301_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jad.2017.02.012","volume":"213","author":"L Lindstr\u00f6m","year":"2017","unstructured":"Lindstr\u00f6m L, Lindstr\u00f6m E, Nilsson M, H\u00f6istad M. Maintenance therapy with second generation antipsychotics for bipolar disorder\u2014a systematic review and meta-analysis. J Affect Disord. 2017;213:138\u201350.","journal-title":"J Affect Disord"},{"issue":"1","key":"301_CR26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1192\/bjp.2019.16","volume":"215","author":"LM Lyall","year":"2019","unstructured":"Lyall LM, Penades N, Smith DJ. Changes in prescribing for bipolar disorder between 2009 and 2016: national-level data linkage study in Scotland. Br J Psychiatry. 2019;215(1):415\u201321.","journal-title":"Br J Psychiatry"},{"key":"301_CR27","doi-asserted-by":"publisher","DOI":"10.3109\/00048670903279937","author":"GS Malhi","year":"2009","unstructured":"Malhi GS, Adams D, Berk M. Is lithium in a class of its own? A Brief Profile of Its Clinical Use. 2009. https:\/\/doi.org\/10.3109\/00048670903279937.","journal-title":"A Brief Profile of Its Clinical Use"},{"issue":"4","key":"301_CR28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/bdi.12942","volume":"22","author":"GS Malhi","year":"2020","unstructured":"Malhi GS, Bell E, Boyce P, Hazell P, Murray G, Bassett D, et al. Make lithium great again! Bipolar Disord. 2020;22(4):325\u20137.","journal-title":"Bipolar Disord"},{"key":"301_CR29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jad.2017.03.052","volume":"217","author":"GS Malhi","year":"2017","unstructured":"Malhi GS, Gessler D, Outhred T. The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines. J Affect Disord. 2017;217:266\u201380.","journal-title":"J Affect Disord"},{"issue":"5","key":"301_CR30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4103\/psychiatry.IndianJPsychiatry_484_18","volume":"61","author":"S Mandal","year":"2019","unstructured":"Mandal S, Mamidipalli S, Mukherjee B, Hara S. Perspectives, attitude, and practice of lithium prescription among psychiatrists in India. Indian J Psychiatry. 2019;61(5):451.","journal-title":"Indian J Psychiatry"},{"issue":"1","key":"301_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","volume":"1","author":"T Miura","year":"2014","unstructured":"Miura T, Noma H, Furukawa TA, Mitsuyasu H, Tanaka S, Stockton S, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1(1):351\u20139.","journal-title":"Lancet Psychiatry"},{"key":"301_CR32","doi-asserted-by":"crossref","first-page":"638377","DOI":"10.3389\/fpsyg.2021.638377","volume":"12","author":"O Muhorakeye","year":"2021","unstructured":"Muhorakeye O, Biracyaza E. Exploring barriers to mental health services utilization at kabutare district hospital of Rwanda: perspectives from patients. Front Psychol. 2021;12:638377.","journal-title":"Front Psychol"},{"issue":"1","key":"301_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40345-020-00191-4","volume":"8","author":"A Murru","year":"2020","unstructured":"Murru A, Manchia M, Hajek T, Nielsen RE, Rybakowski JK, Sani G, et al. Lithium\u2019s antiviral effects: a potential drug for CoViD-19 disease? Int J Bipolar Disord. 2020;8(1):19.","journal-title":"Int J Bipolar Disord"},{"issue":"1","key":"301_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-018-0120-1","volume":"6","author":"M Nederlof","year":"2018","unstructured":"Nederlof M, Heerdink ER, Egberts ACG, Wilting I, Stoker LJ, Hoekstra R, et al.Monitoring of patients treated with lithium for bipolar disorder: an international survey. Int J Bipolar Disord. 2018;6(1):1\u20139.","journal-title":"Int J Bipolar Disord"},{"key":"301_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2021.08.264","volume":"54","author":"A Nestsiarovich","year":"2022","unstructured":"Nestsiarovich A, Gaudiot CES, Baldessarini RJ, Vieta E, Zhu Y, Tohen M. Preventing new episodes of bipolar disorder in adults: systematic review and meta-analysis of randomized controlled trials. Eur Neuropsychopharmacol. 2022;54:75\u201389.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"05","key":"301_CR36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0043-125393","volume":"51","author":"R Nielsen","year":"2018","unstructured":"Nielsen R, Kessing L, Nolen W, Licht R. Lithium and renal impairment: a review on a still hot topic. Pharmacopsychiatry. 2018;51(05):200\u20135.","journal-title":"Pharmacopsychiatry"},{"key":"301_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118760663","author":"VL Nikolova","year":"2018","unstructured":"Nikolova VL, Pattanaseri K, Hidalgo-Mazzei D, Taylor D, Young AH. Is lithium monitoring NICE? Lithium monit UK secondary care sett. 2018. https:\/\/doi.org\/10.1177\/0269881118760663.","journal-title":"Lithium monit UK secondary care sett"},{"issue":"5","key":"301_CR38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bdi.12805","volume":"21","author":"WA Nolen","year":"2019","unstructured":"Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, et al. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD\/IGSLI task force on treatment with lithium. Bipolar Disord. 2019;21(5):394\u2013409.","journal-title":"Bipolar Disord"},{"key":"301_CR39","first-page":"172","volume":"23","author":"B Pacciardi","year":"2017","unstructured":"Pacciardi B, Palagini L, Mainardi C, Cotugno B, Cargioli C, Perugi G, et al. Attitude toward prescription and clinical monitoring of lithium salts in a sample of Italian psychiatrists: preliminary data. Off J Ital Soc Psychopathol. 2017;23:172\u20139.","journal-title":"Off J Ital Soc Psychopathol"},{"issue":"12","key":"301_CR40","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1177\/0269881110367728","volume":"24","author":"C Paton","year":"2010","unstructured":"Paton C, Barnes TRE, Shingleton-Smith A, McAllister-Williams HR, Kirkbride J, Jones PB, et al. Lithium in bipolar and other affective disorders: prescribing practice in the UK. J Psychopharmacol. 2010;24(12):1739\u201346.","journal-title":"J Psychopharmacol"},{"key":"301_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/1178632917694350","author":"S Rathod","year":"2017","unstructured":"Rathod S, Pinninti N, Irfan M, Gorczynski P, Rathod P, Gega L, et al. Mental health service provision in low- and middle-income countries. Health Serv Insights. 2017. https:\/\/doi.org\/10.1177\/1178632917694350.","journal-title":"Health Serv Insights"},{"issue":"8","key":"301_CR42","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1176\/appi.ajp.2020.19091000","volume":"177","author":"TG Rhee","year":"2020","unstructured":"Rhee TG, Olfson M, Nierenberg AA, Wilkinson ST. 20-years Trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. Am J Psychiatry. 2020;177(8):706.","journal-title":"Am J Psychiatry"},{"key":"301_CR43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.euroneuro.2022.01.111","volume":"57","author":"JK Rybakowski","year":"2022","unstructured":"Rybakowski JK. Lithium. Eur Neuropsychopharmacol. 2022;57:86\u20137.","journal-title":"Eur Neuropsychopharmacol"},{"key":"301_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-018-0892-0","volume":"20","author":"L Samalin","year":"2018","unstructured":"Samalin L, Genty JB, Boyer L, Lopez-Castroman J, Abbar M, Llorca PM. Shared decision-making: a systematic review focusing on mood disorders. Curr Psychiatry Rep. 2018;20:1\u20131.","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"301_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-018-1686-y","volume":"18","author":"L Samalin","year":"2018","unstructured":"Samalin L, Honciuc M, Boyer L, de Chazeron I, Blanc O, Abbar M, et al. Efficacy of shared decision-making on treatment adherence of patients with bipolar disorder: a cluster randomized trial (ShareD-BD). BMC Psychiatry. 2018;18(1):1.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"301_CR46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/bdi.13154","volume":"24","author":"G Schoretsanitis","year":"2022","unstructured":"Schoretsanitis G, de Filippis R, Brady BM, Homan P, Suppes T, Kane JM. Prevalence of impaired kidney function in patients with long-term lithium treatment: a systematic review and meta-analysis. Bipolar Disord. 2022;24(3):264\u201374.","journal-title":"Bipolar Disord"},{"issue":"2","key":"301_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0033-1363258","volume":"47","author":"V Selle","year":"2014","unstructured":"Selle V, Schalkwijk S, V\u00e1zquez GH, Baldessarini RJ. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry. 2014;47(2):43\u201352.","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"301_CR48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/bdi.12714","volume":"21","author":"KI Shulman","year":"2019","unstructured":"Shulman KI, Almeida OP, Herrmann N, Schaffer A, Strejilevich SA, Paternoster C, et al. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: an ISBD task force report. Bipolar Disord. 2019;21(2):117\u201323.","journal-title":"Bipolar Disord"},{"issue":"1","key":"301_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-021-00223-7","volume":"9","author":"M Sk\u00f6ld","year":"2021","unstructured":"Sk\u00f6ld M, Rolstad S, Joas E, Kardell M, P\u00e5lsson E, Goodwin GM, et al. Regional lithium prescription rates and recurrence in bipolar disorder. Int J Bipolar Disord. 2021;9(1):1\u20139.","journal-title":"Int J Bipolar Disord"},{"issue":"7","key":"301_CR50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/bdi.12543","volume":"19","author":"KA Smith","year":"2017","unstructured":"Smith KA, Cipriani A. Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord. 2017;19(7):575\u201386.","journal-title":"Bipolar Disord"},{"key":"301_CR51","first-page":"3","volume":"22","author":"SA Strejilevich","year":"2011","unstructured":"Strejilevich SA, Urtueta-Baamonde M, Teitelbaum J, Martino DJ, Marengo E, Igoa A, et al. Clinical concepts associated with lithium underutilization in the treatment of bipolar disorder. Vertex. 2011;22:3\u201320.","journal-title":"Vertex"},{"issue":"2","key":"301_CR52","first-page":"139","volume":"16","author":"F Williams","year":"2008","unstructured":"Williams F, Boren SA. The role of the electronic medical record (EMR) in care delivery development in developing countries: a systematic review. Inf Prim Care. 2008;16(2):139\u201345.","journal-title":"Inf Prim Care"},{"issue":"12","key":"301_CR53","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/ijms18122679","volume":"18","author":"E Won","year":"2017","unstructured":"Won E, Kim YK. An oldie but goodie: lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms. Int J Mol Sci. 2017;18(12):2679.","journal-title":"Int J Mol Sci"},{"key":"301_CR54","unstructured":"World Health Organization (WHO). mhGAP intervention guide for mental, neurological and substance use disorders in nonspecialized\nhealth settings: mental health gap action programme (mhGAP). 2016."},{"issue":"6","key":"301_CR55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1192\/bjp.bp.107.043133","volume":"191","author":"AH Young","year":"2007","unstructured":"Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use?. Br J Psychiatry. 2007;191(6):474\u20136.","journal-title":"Br J Psychiatry"}],"container-title":["International Journal of Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-023-00301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40345-023-00301-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-023-00301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T02:22:45Z","timestamp":1687486965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalbipolardisorders.springeropen.com\/articles\/10.1186\/s40345-023-00301-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1186\/s40345-023-00301-y","relation":{},"ISSN":["2194-7511"],"issn-type":[{"value":"2194-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,27]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided electronic approval to participate in the study prior to completing the anonymous survey. Ethical review and approval were waived for this study as it did not involve any patients or animals but just medical professionals responding an anonymized survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0and consent to participate"}},{"value":"All authors contributed to and approved the final manuscript giving their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Diego Hidalgo-Mazzei has received CME-related honoraria and served as consultant for Abbott, Angelini, Ethypharm Digital Therapy and Janssen-Cilag with no financial or other relationship relevant to the subject of this article. Ludovic Samalin has received CME-related honoraria and served as consultant for Janssen-Cilag, Lundbeck, Otsuka, Sanofi-Aventis with no financial or other relationship relevant to the subject of this article. Juan Undurraga has served as a consultant for Johnson & Johnson.   Michael Bauer has received research grants by the Deutsche Forschungsgemeinschaft (DFG), Bundesministerium f\u00fcr Bildung und Forschung (BMBF), Gemeinsamer Bundesausschuss- Innovationsausschuss, European Commission, S\u00e4chsisches Staatsministerium f\u00fcr Wissenschaft, Kultur und Tourismus (SMWK) and served as consultant, adviser or speaker for Biogen, Janssen-Cilag, GH Research, Livanova Deutschland GmbH, Novartis, Sunovion, Takeda, neuraxpharm, Shire International GmbH, Aristo, Servier Deutschland GmbH and Hexal AG. Allan H. Young has received honoraria for lectures and advisory boards for all major pharmaceutical companies with drugs used in affective and related disorders with no financial or other relationship relevant to the subject of this article.Eduard Vieta has received research support from or served as consultant, adviser or speaker for AB-Biotics, Abbott, Abbvie, Adamed, Angelini, Biogen, Celon, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, GH Research, Glaxo SimthKline, Janssen, Lundbeck, Organon, Otsuka, Rovi, Sage pharmaceuticals, Sanofi-Aventis, Shire, Sunovion, Takeda, and Viatris, out of the submitted work. The other authors do not report any financial or other relationship relevant to the subject of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}